New brain imaging agent could revolutionize Alzheimer's diagnosis
NCT ID NCT05542953
First seen Nov 01, 2025 · Last updated May 25, 2026 · Updated 28 times
Summary
This study tested a new imaging agent called [18F]APN-1607 to see if it can help diagnose Alzheimer's disease by detecting specific brain changes. About 230 people took part, including those with Alzheimer's, mild cognitive impairment, and healthy volunteers. The goal was to compare brain scan patterns among these groups to improve early and accurate diagnosis.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Union Hospital Tongji Medical College Huazhong University of Science and Technology
Wuhan, Hubei, 430000, China
Conditions
Explore the condition pages connected to this study.